Nicholas Khadder - 20 May 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting relationship: SVP, Gen. Counsel & Secretary
Issuer ticker: LAB
Reported as of: 20 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2022, 20:16:09 UTC
Prior SEC filing: 24 Feb 2022
Next SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Nicholas Khadder

Key filing fact

Nicholas Khadder filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 23 May 2022.

Key facts

This page summarizes Nicholas Khadder's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
7 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 23 May 2022, 20:16.

Change

Previous filing in this sequence was filed on 24 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAB transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +4,063
Change %: +4.9%
Price: $0.000000
Shares after: 86,454
Date: 20 May 2022
Ownership: Direct

LAB transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +15,000
Change %: +17%
Price: $0.000000
Shares after: 101,454
Date: 20 May 2022
Ownership: Direct

LAB transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +9,846
Change %: +9.7%
Price: $0.000000
Shares after: 111,300
Date: 20 May 2022
Ownership: Direct

LAB transaction

Common Stock

Tax liability

Transaction value: $0
Shares: -14,161
Change %: -13%
Price: $0.000000
Shares after: 97,139
Date: 20 May 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -4,063
Change %: -11%
Price: $0.000000
Shares after: 32,500
Date: 20 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,063
Exercise price
Footnotes: F1, F2

LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -15,000
Change %: -50%
Price: $0.000000
Shares after: 15,000
Date: 20 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price
Footnotes: F1, F3

LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -9,846
Change %: -25%
Price: $0.000000
Shares after: 29,541
Date: 20 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,846
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

Footnote F2

On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Footnote F3

On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

Footnote F4

On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.